The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus
NCT00463502 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2007-04-20
Summary
Aim: To investigate the effects of metformin treatment on thyroid hormone metabolism in euthyroid patients with type 2 diabetes mellitus.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
Sponsors & Collaborators
-
Haydarpasa Numune State Hospital
lead OTHER
Principal Investigators
-
Ali Ozdemir · Unaffiliation
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 35 Years
- Max Age
- 78 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin
NCT02438397 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Metformin on Blood Vessel Structure and Function
NCT00105066 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
NCT03590262 ·Status: UNKNOWN ·Phase: PHASE4
-
Metformin Therapy in Type 1 Diabetes Mellitus.
NCT01889706 ·Status: UNKNOWN
-
Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes
NCT04426422 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly
NCT02125305 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs
NCT01068652 ·Status: COMPLETED ·Phase: PHASE4
-
Metformin for the Treatment of Diabetes in Pregnancy
NCT00414245 ·Status: UNKNOWN ·Phase: PHASE3
-
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
NCT02535299 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of BMS-986165 on the Blood Levels of Metformin
NCT04671953 ·Status: COMPLETED ·Phase: PHASE1
-
Antidiabetic Effects on Intrahepatic Fat
NCT03068065 ·Status: COMPLETED ·Phase: PHASE4
-
Metformin in Postmenopausal Women With Metabolic Syndrome
NCT01342744 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome
NCT02633488 ·Status: COMPLETED ·Phase: NA
-
Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
NCT01968317 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin Plus Insulin on Non-obese Autoimmune Diabetes
NCT03513874 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
NCT00568984 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin
NCT01929863 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DM
NCT02765347 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
NCT02143765 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus
NCT01509001 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.
NCT01443221 ·Status: COMPLETED ·Phase: PHASE1
-
Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin
NCT04659915 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin
NCT00970593 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs
NCT00491725 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes
NCT04390295 ·Status: UNKNOWN ·Phase: PHASE3